Flare Therapeutics Company
Therapeutics Targeting Transcription Factors
Industry:
Small & Large Molecules
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
1/1/2021
Employees Number:
1-10
Funding Status:
Early Stage Venture
Total Funding:
82000000
Last Funding Type:
Series A
Register and Claim Ownership